{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:33:30Z","timestamp":1774611210436,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/wnf.0b013e31829b99d9","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T11:21:50Z","timestamp":1373973710000},"page":"128-130","source":"Crossref","is-referenced-by-count":10,"title":["Covert Dyskinesia Associated With Aripiprazole"],"prefix":"10.1097","volume":"36","author":[{"given":"Carrie N.","family":"Moseley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather A.","family":"Simpson-Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-6-20210203","first-page":"651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.","volume":"160","author":"Keck","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R3-6-20210203","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4088\/PCC.08m00744gre","article-title":"Safety and tolerability of adjunctive aripiprazole in major depressive disorder: a pooled post hoc analysis (studies CN138-139 and CN138-163).","volume":"11","author":"Nelson","year":"2009","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archpsyc.60.10.974","article-title":"Mechanism of new antipsychotic medications: occupancy is not just antagonism.","volume":"60","author":"Grunder","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R8-6-20210203","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1345\/aph.1E288","article-title":"Aripiprazole-associated dyskinesia.","volume":"39","author":"Sajbel","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R10-6-20210203","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.pnpbp.2007.06.010","article-title":"Aripiprazole in the treatment of tardive dyskinesia induced by other atypical antipsychotics.","volume":"31","author":"Lykouras","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R11-6-20210203","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/JCP.0b013e31819a4bd5","article-title":"Tardive dyskinesia due to aripiprazole.","volume":"29","author":"Lungu","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"R12-6-20210203","first-page":"32","article-title":"Aripiprazole (Abilify) and tardive dyskinesia.","volume":"33","author":"Schwartz","year":"2008","journal-title":"PT"},{"key":"R13-6-20210203","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S1092852900014632","article-title":"Aripiprazole-related tardive dyskinesia.","volume":"11","author":"Maytal","year":"2006","journal-title":"CNS Spectr"},{"key":"R14-6-20210203","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mds.23402","article-title":"Tardive dyskinesia and other movement disorders secondary to aripiprazole.","volume":"26","author":"Pena","year":"2011","journal-title":"Mov Disord"},{"key":"R15-6-20210203","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/JCP.0b013e31815a5870","article-title":"Atypical antipsychotic withdrawal dyskinesia in 4 patients with mood disorders.","volume":"27","author":"Urbano","year":"2007","journal-title":"J Clin Psychopharmacol"},{"issue":"Suppl 9","key":"R16-6-20210203","first-page":"25","article-title":"Pathophysiology of antipsychotic drug-induced movement disorders.","volume":"65","author":"Casey","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R17-6-20210203","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1176\/ajp.135.11.1321","article-title":"Withdrawal syndromes associated with antipsychotic drugs.","volume":"135","author":"Gardos","year":"1978","journal-title":"Am J Psychiatry"},{"key":"R19-6-20210203","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/cap.2010.0030","article-title":"Methylphenidate treatment and dyskinesia in children with attention deficithyperactivity disorder.","volume":"21","author":"Balazs","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R20-6-20210203","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/cap.2006.0055","article-title":"Methylphenidate-induced orofacial and extremity dyskinesia.","volume":"17","author":"Balazs","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R21-6-20210203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00005053-197407000-00006","article-title":"Iatrogenic dyskinesia: a unique reaction to parenteral methyphenidate.","volume":"159","author":"Palatucci","year":"1974","journal-title":"J Nerv Ment Dis"},{"key":"R22-6-20210203","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0006-3223(95)00082-8","article-title":"Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.","volume":"38","author":"Schultz","year":"1995","journal-title":"Biol Psychiatry"},{"key":"R23-6-20210203","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1176\/ajp.140.5.611","article-title":"Late-onset akathisiaan indicant of covert dyskinesia: two case reports.","volume":"140","author":"Braude","year":"1983","journal-title":"Am J Psychiatry"},{"key":"R24-6-20210203","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/FBP.0b013e32834aff6d","article-title":"B vitamins attenuate haqloperidol-induced orofacial dyskinesia in rats: possible involvement of antioxidant mechanisms.","volume":"22","author":"Macedo","year":"2011","journal-title":"Behav Pharmacol"},{"key":"R25-6-20210203","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/WNF.0b013e3181ffde32","article-title":"Effects of amantadine on tardive dyskinesia: a randomized, double-blind, placebo controlled study.","volume":"33","author":"Pappa","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"R27-6-20210203","first-page":"589","article-title":"Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics Movement D","volume":"21","author":"Tarsy","year":"2006","journal-title":"isorders"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0b013e31829b99d9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:15:30Z","timestamp":1620976530000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201307000-00006"}},"subtitle":["A Case Report and Review of the Literature"],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e31829b99d9","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}